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Ataxia-Telangiectasia (A-T) is an incurable and rare hereditary syndrome. Treatment with glucocorticoids 
(GCs) leads to a variable improvement of the neurological and immunological phenotype. We wondered 
whether there was a correlation between the behavior of lymphocytes functionality and the neurological 
response to the GC administration. We found that the proliferative response to PHA or IL-7 showed a increase 
only in 2 of the 4 A-T patients, referred at a single Center. A correlation between the proliferative response 
to IL-7 and the percentage of CD3+CD127+ cells was found. A significant inverse relationship between the 
proliferative response to IL-7 and the behavior of the SARA score was found. Subcellular localization studies 
revealed that, only in the responders, IL-7Rα was localized into the early endosome (EEA1) vesicles and 
recycled back to the cell surface through the late endosomes (Rab-7). Using microarray analysis we have 
identified 4304 differently expressed genes (DEgenes), in PBMCs from the only A-T responder patient studied 
before or after GC treatment. Of these, 2933 transcripts decreased and 1371 transcripts exhibited an 
increased transcription. Interestingly, some DE-genes are implicated in pathways relevant for A-T 
pathogenesis, such as cell proliferation, regeneration and differentiation, endosomal/lysosomal trafficking 
and inflammation. In conclusion, our data indicate a tight correlation in A-T between the in vivo neurological 
response to GC and the in vitro lymphocyte behavior, and that in-vitro studies on lymphocyte functionality 
are an excellent cellular model to achieve a better understanding of the disease pathogenesis and of the 
mechanism of action of GC. 
 
